JP Morgan Maintains Underweight on CME Gr, Raises Price Target to $191
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Kenneth Worthington maintains an Underweight rating on CME Group (NASDAQ:CME) but raises the price target from $187 to $191.
July 25, 2024 | 1:34 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
JP Morgan analyst Kenneth Worthington maintains an Underweight rating on CME Group but raises the price target from $187 to $191.
The Underweight rating suggests a bearish outlook, but the raised price target indicates some positive expectations. The net impact is likely neutral in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100